Skip to main content
VYNE logo
VYNE
(NASDAQ)
VYNE Therapeutics Inc.
$0.60-- (--)
Loading... - Market loading

VYNE Therapeutics (VYNE) Stock Price & Financial Analysis

VYNE Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.59 - $0.61
52-Week High$1.99
52-Week Low$0.28
Open$0.61
Volume117.84K
Average Volume (3M)117.84K
Market Cap25.70M
Shares Outstanding42.77M
Price to Sales (P/S)45.47
Price to Book (P/B)0.93
EV/EBITDA-0.06
Revenue (TTM)570.00K
Net Income (TTM)-26.48M
EPS (TTM)$-0.62
Profit Margin-4646.14%
Operating Margin-5219.12%
Return on Equity (ROE)-95.38%
Debt to Equity0.00
50-Day MA$0.59
200-Day MA$0.58
52-Week Change-60.39%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About VYNE Therapeutics

What is the current stock price for VYNE?

As of the latest trading session, VYNE stock trades at $0.60. The 52-week range is $0.28–$1.99, with a day range of $0.59–$0.61.

What is the P/E ratio for VYNE?

The P/E ratio (Price-to-Earnings) for VYNE is shown in the Key Statistics section. This valuation metric helps compare VYNE Therapeutics Inc. to industry peers.

Does VYNE pay dividends?

VYNE Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VYNE?

Analyst ratings and recommendations for VYNE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of VYNE?

VYNE Therapeutics's market capitalization is $25.7M, classifying it as a micro-cap company. VYNE Therapeutics operates in the Healthcare sector within the Biotechnology industry.